Ventyx Biosciences Inc

NEW
NAS:VTYX (USA)  
$ 1.39 -0.070 (-4.79%) 07:08 PM EST
At Loss
P/B:
0.39
Market Cap:
$ 98.87M
Enterprise V:
$ -102.68M
Volume:
505.17K
Avg Vol (2M):
1.22M
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
505.17K
At Loss
Avg Vol (2M):
1.22M

Business Description

Ventyx Biosciences Inc
NAICS : 541713 SIC : 2833
ISIN : US92332V1070
Description
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
Name Current Vs Industry Vs History
Cash-To-Debt 20.13
Equity-to-Asset 0.92
Debt-to-Equity 0.04
Debt-to-EBITDA -0.07
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 17.97
Quick Ratio 17.97
Cash Ratio 17.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.2
Shareholder Yield % -101.51

Financials (Next Earnings Date:2025-05-09 Est.)

VTYX's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VTYX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Ventyx Biosciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.98
Beta 0.36
3-Year Sharpe Ratio 0.25
3-Year Sortino Ratio 0.54
Volatility % 77.05
14-Day RSI 35.01
14-Day ATR ($) 0.124844
20-Day SMA ($) 1.574
12-1 Month Momentum % -80.02
52-Week Range ($) 1.34 - 8.48
Shares Outstanding (Mil) 71.13

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ventyx Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Ventyx Biosciences Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Ventyx Biosciences Inc Frequently Asked Questions

What is Ventyx Biosciences Inc(VTYX)'s stock price today?
The current price of VTYX is $1.39. The 52 week high of VTYX is $8.48 and 52 week low is $1.34.
When is next earnings date of Ventyx Biosciences Inc(VTYX)?
The next earnings date of Ventyx Biosciences Inc(VTYX) is 2025-05-09 Est..
Does Ventyx Biosciences Inc(VTYX) pay dividends? If so, how much?
Ventyx Biosciences Inc(VTYX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1